Integrating Chinese and conventional medicine in colorectal cancer treatment.
The Chinese have been integrating cancer treatment for the past 60 years. Using conventional and Chinese traditional medicine, this integration has evolved into a sophisticated hybrid of medicine that has generated a great deal of well-designed research demonstrating that the use of combined care can improve outcomes for patients with cancer. This article seeks to explain the integration in terms of treatment of colorectal cancer and a colorectal cancer case with Duke's stage C adenocarcinoma.
Lahans
Tai
T
3800 East Jefferson Street, Seattle, WA 98122, USA. lahans9@aol.com
D000230:Adenocarcinoma / Q000628:therapy*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000628:therapy*; D003131:Combined Modality Therapy; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004365:Drugs, Chinese Herbal; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use*; D008297:Male; D008516:Medicine, Chinese Traditional; D008875:Middle Aged; D000093542:Gemcitabine
D000970:Antineoplastic Agents; D004365:Drugs, Chinese Herbal; D003841:Deoxycytidine; D002955:Leucovorin; D005472:Fluorouracil; D000093542:Gemcitabine